These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9299630)

  • 1. Inhibition of vaccinia virus replication by N-(phosphonoacetyl)-L-aspartate: differential effects on viral gene expression result from a reduced pyrimidine nucleotide pool.
    Katsafanas GC; Grem JL; Blough HA; Moss B
    Virology; 1997 Sep; 236(1):177-87. PubMed ID: 9299630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD; Smith PA; Levy EJ; Handschumacher RE
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
    Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
    Chan TC; Howell SB
    Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
    Moore EC; Friedman J; Valdivieso M; Plunkett W; Marti JR; Russ J; Loo TL
    Biochem Pharmacol; 1982 Oct; 31(20):3317-21. PubMed ID: 7150358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs.
    Kane EM; Shuman S
    J Virol; 1995 Oct; 69(10):6352-8. PubMed ID: 7666536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26.
    van Laar JA; Durrani FA; Rustum YM
    Cancer Res; 1993 Apr; 53(7):1560-4. PubMed ID: 8453623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
    Yang JL; Fernandes DJ; Wheeler KT; Capizzi RL
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1073-9. PubMed ID: 8600090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines.
    Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL
    Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis.
    Broyles SS; Kremer M; Knutson BA
    J Virol; 2004 Feb; 78(4):2137-41. PubMed ID: 14747579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles.
    Poupon MF; Smith KA; Chernova OB; Gilbert C; Stark GR
    Mol Biol Cell; 1996 Mar; 7(3):345-54. PubMed ID: 8868464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
    Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S; Rauscher F; Jakubowski A; Cadman E
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine.
    Garcia RA; Liu L; Hu Z; Gonzalez A; von Borstel RW; Saydoff JA
    Brain Res; 2005 Dec; 1066(1-2):164-71. PubMed ID: 16330000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin, an inhibitor of vaccinia virus replication.
    Takeshita M; Horwitz SB; Grollman AP
    Virology; 1974 Aug; 60(2):455-65. PubMed ID: 4135910
    [No Abstract]   [Full Text] [Related]  

  • 17. Salvage of circulating pyrimidine nucleosides in the rat.
    Moyer JD; Oliver JT; Handschumacher RE
    Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartate.
    Wiley RG; Gralla RJ; Casper ES; Kemeny N
    Ann Neurol; 1982 Aug; 12(2):175-83. PubMed ID: 7125606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole.
    Tessera L; Mucciolo E; Bertoni L; Giulotto E
    Anticancer Res; 1995; 15(1):189-92. PubMed ID: 7733632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture.
    Schnellrath LC; Damaso CR
    Int J Antimicrob Agents; 2011 Nov; 38(5):435-41. PubMed ID: 21840180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.